UBS initiated coverage on Galecto with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for GLTO
Across the 9 sessions after earlier GLTO headlines, the stock closed higher 4 times and lower 5 times, with a median move of 3.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GLTO | SPY |
|---|---|---|---|
| Feb 13, 2026 | Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million | -3.0% | +0.1% |
| Feb 11, 2026 | Galecto Announces Pricing of $275 Million Underwritten Public Offeringand 1 other headline that session | +1.3% | -0.0% |
| Jan 12, 2026 | Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones | +6.4% | +0.2% |
| Jan 7, 2026 | Leerink Partners initiated coverage on Galecto with a new price target | -3.8% | -0.3% |
| Jan 6, 2026 | Galecto Announces Key Additions to Leadership Team | +2.7% | +0.6% |
| Dec 17, 2025 | Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | -12.2% | -1.1% |
Quantisnow market dataNASDAQ
GLTO
Galecto Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for GLTO
Full GLTO profile on Quantisnow Follow GLTO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time